Adjuvance Technologies Announces First Clinical Results of its Next-generation Saponin Adjuvant
Business Wire India Adjuvance Technologies Inc., a privately held clinical-stage biopharmaceutical company developing saponin adjuvants and vaccines for infectious disease and immuno-oncology, announced that its adjuvant TQL-1055 was safe and…